Qvir KIT
Product Details:
- Molecular Formula C23H32F2N4O4 (Nirmatrelvir) + C37H48N6O3S2 (Ritonavir)
- Indication Treatment of COVID-19 in adults with mild to moderate symptoms
- Storage Store below 30C in a dry place away from direct sunlight
- CAS No 1809249-37-3 1379741-00-6 (for Nirmatrelvir and Ritonavir)
- Salt Composition Nirmatrelvir and Ritonavir
- Dosage As directed by the physician
- Grade Pharmaceutical
X
Qvir KIT Product Specifications
- 1809249-37-3 1379741-00-6 (for Nirmatrelvir and Ritonavir)
- As directed by the physician
- Nirmatrelvir and Ritonavir
- C23H32F2N4O4 (Nirmatrelvir) + C37H48N6O3S2 (Ritonavir)
- Treatment of COVID-19 in adults with mild to moderate symptoms
- Store below 30C in a dry place away from direct sunlight
- India
- Film-coated tablets
- Nirmatrelvir 150 mg + Ritonavir 100 mg per dose
- Pharmaceutical
- 24 months from the date of manufacture
- 17 tablets per kit
- Antiviral Combination Therapy
- Oral administration for the prescribed duration
- Tablet
Product Description
The four drug kit contains Tenofovir, Emtricitabine, Atazanavir and Ritonavir. These drugs can be used for both first and second line treatment of HIV.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Antiviral Drugs' category
We deal in bulk foreign inquiries.
ACTIZA PHARMACEUTICAL PRIVATE LIMITED
GST : 24AAPCA8809B1ZQ
GST : 24AAPCA8809B1ZQ
Contact Details
- 245-405, Royal Square, Utran, Surat - 394105, Gujarat, India
- Phone : 07971189326
- Mr Milan Sojitra (BDM)
- Mobile : 07971189326
|
ACTIZA PHARMACEUTICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
